Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> JOHNSON & JOHNSON Latest News

JUL 22, 2014 - TheStreet

A Must Read - Share

Why Johnson & Johnson (JNJ) Stock Is Up Today

NEW YORK (TheStreet) -- Johnson & Johnson shares are climbing, up 1.18% to $102.46 on Tuesday, after the company announced plans for a $5 billion stock buyback program.The timetable for the buybacks is open ended and left up to the discretion of the company's management. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a ...

Tags: Why Johnson & Johnson (JNJ) Stock Is Up Today,  Johnson & Johnson Latest News

JUL 21, 2014 - Wall Street Journal

A Must Read - Share

J&J Adds $5 Billion to Stock Buyback Program

Johnson & Johnson said its board approved an additional $5 billion in stock buybacks.

Tags: J&J Adds $5 Billion to Stock Buyback Program,  Johnson & Johnson Latest News

JUL 21, 2014 - MarketWatch

A Must Read - Share

Johnson & Johnson sets $5 billion share buyback

SAN FRANCISCO (MarketWatch) -- Healthcare giant Johnson & Johnson announced late Monday the company's board has approved a $5 billion buyback program of its common stock. Timing of the buybacks is open ended and will be left to the discretion of management. The company, a component of the Dow Jones Industrial Average, had 2.82 billion shares outstanding as of June ...

Tags: Johnson & Johnson sets $5 billion share buyback,  Johnson & Johnson Latest News

JUL 21, 2014 - TheStreet

A Must Read - Share

Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend

NEW YORK (TheStreet) -- Johnson & Johnson declares a quarterly dividend of 70 cents a share Monday. Shares of Jonson & Johnson was falling -0.7% to $101.10. The quarterly dividend is in line with the company's previous. The dividend is payable on Sept. 9 to all shareholders of record as of Aug. 26. The ex-dividend date is Aug. 22. Must read: ...

Tags: Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend,  Johnson & Johnson Latest News

JUL 17, 2014 - Philadelphia Inquirer

A Must Read - Share

J&J shares fall amid concern on competition for hepatitis drug

While Johnson & Johnson's new hepatitis C pill Olysio has had blockbuster revenue in 2014, concerns the sales surge probably won't last drove down shares.

Tags: J&J shares fall amid concern on competition for hepatitis drug,  Johnson & Johnson Latest News